A Phase III, Multicenter, Randomized, Double¿Masked, Sham¿Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema
Clinical Trial Grant
Administered By
Ophthalmology, Corneal Diseases
Awarded By
Genentech, Inc.
Start Date
July 3, 2023
End Date
April 14, 2028
Administered By
Ophthalmology, Corneal Diseases
Awarded By
Genentech, Inc.
Start Date
July 3, 2023
End Date
April 14, 2028